Healthtech Late Stage Investors & VC Firms
494 firms in this list, with a median first check of $1M. 98 of them lead rounds. Generated from verified public data and updated continuously.
Jacobs Holding AG
ZurichGrowth–Late Stage$100M – $300M
23 people
Perennial Partners
SydneyGrowth–Late Stage
1 person
Elysian
LondonGrowth–Late Stage
18 people
Magnum Industrial Partners Tres S.L.
MadridGrowth–Late Stage
17 people
Black Opal Ventures
New YorkSeed–Late Stage
18 people
Nordic Capital
StockholmGrowth–Late Stage
12 people
Oberland Capital
New YorkGrowth–Late Stage
20 people
New Alliance Capital
ShanghaiSeed–Late Stage
25 people
MSD Global Health Innovation Fund
RahwaySeries A–Late Stage$2M – $10M
10 people
SPE Capital Partners
CairoGrowth–Late Stage
19 people
Southern Cross Group
SantiagoGrowth–Late Stage
15 people
Brookstreet Equity Partners
LondonSeries A–Late Stage
22 people
Creathor Ventures
Bad HomburgSeed–Late Stage$540K – $10.8M
2 people
Phatisa
BambouGrowth–Late Stage
18 people
BC Partners
LondonGrowth–Late Stage
23 people
ISALT - Investissements Stratégiques en Actions Long Terme
ParisGrowth–Late Stage
23 people
Keensight Capital
ParisGrowth–Late Stage$10M – $800M
4 people
DNA Capital
São PauloSeed–Late Stage$100K – $5M
15 people
Invus
New YorkSeed–Late Stage
8 people
HBM Partners
ZugSeed–Late Stage$5M – $50M
6 people
Pappas Capital
Research Triangle ParkSeed–Late Stage$100K – $6M
15 people
Camino Partners
AustinGrowth–Late Stage
18 people
JK&B Capital
ChicagoSeed–Late Stage
9 people
Ally Bridge Group
New YorkGrowth–Late Stage
7 people
Related lists
Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Late Stage Investors & VC Firms (1725)Healthtech Pre-Seed Investors & VC Firms (1468)Healthtech Investors & VC Firms in Europe (1358)Healthtech Growth Investors & VC Firms (1270)Healthtech Investors & VC Firms in Global (1182)
Data sourced from public filings and firms' own websites — see our methodology.































































































